ATP6AP2 and neoplasm: To further investigate whether the suppression of Atp6ap2 gene expression shows any synergistic effects in combination with already established anti-tumor treatments, INS-1 cells were treated with Atp6ap2 siRNA-1 and/or octreotide, a somatostatin analogue, and the number of apoptotic cells was sequentially quantified with IncuCyte®, a high‐throughput device that can acquire and view culture cell images over time.